---
title: "Reducing Opioid Morbidity and Mortality"
layout: navigation
agency_dir: health_and_human_services
---

    <aside class="usa-width-one-fourth usa-layout-docs-sidenav">
      <ul class="usa-sidenav-list">
        <li>
          <a href="health_and_human_services.html">Department of Health and Human Services</a>
        </li>
        <li>
          <a class="usa-current">Agency Priority Goals</a>
          <ul class="usa-sidenav-sub_list">
            <li>
               <a href="../health_and_human_services/APG_hhs_1.html">Health Security</a>
             </li>
             <li>
                 <a class="usa-current" href="../health_and_human_services/APG_hhs_2.html">Reducing Opioid Morbidity and
Mortality</a>
               </li>
               <li>
              <a href="../health_and_human_services/APG_hhs_3.html">Combined Data Analyses</a>
            </li>
            <li>
                <a href="../health_and_human_services/APG_hhs_4.html">Serious Mental Illness</a>
              </li>
      <!--  <li>   <a href="../health_and_human_services/APG_hhs_5.html">Provider Burden</a>
         </li>
         <li>
              <a href="../health_and_human_services/APG_hhs_6.html">Serious Mental Illness</a>
            </li>-->


          </ul>
      <!--<li>
          <a href="#">Cross Agency Priority Goals</a>
        </li>
        <li>
          <a href="#">FAQs</a>
        </li>-->
      </ul>
    </aside>
     <div class="usa-width-three-fourths usa-layout-docs-main_content">
      <h1>Department of Health and Human Services &nbsp;<a href="https://www.hhs.gov/" target="_blank"><img src="../img/agency/Health_and_Human_Department_Seal.png" alt="HHS seal" align="center" width="87"> </a></h1>
       <h2 id="section-heading-h2">Reducing Opioid Morbidity and Mortality</h2>
       <p><b>Goal Leaders: </b></p>
       <table style="width:100%">
         <tr>
         <td width="17%" align="center"><img src="../img/agr/Circle-icons-profle.svg.png" alt="no photo"  width="100px" ></td>
         <td width="83%" align="left">ADM Brett Giroir, M.D., Assistant Secretary for Health</td>
         </tr>
        <tr>
        <td width="17%" align="center"><img src="../img/agr/Circle-icons-profle.svg.png" alt="no photo"  width="100px" ></td>
        <td width="83%" align="left">Elinore F. McCance-Katz, M.D., Ph.D., Assistant Secretary for Mental Health and Substance Use</td>
        </tr>
        <tr>
        <td width="17%" align="center"><img src="../img/agr/Circle-icons-profle.svg.png" alt="no photo"  width="100px" ></td>
        <td width="83%" align="left">Francis S. Collins, M.D., Ph.D., Director of the National Institutes of Health</td>
        </tr>
      </table>
      <p><b>Deputy Goal Leaders:</b></p>
      <p>Christopher M. Jones, Pharm.D., M.P.H., Substance Abuse and Mental Health Services Administration</p>
      <p>Nora D. Volkow, M.D., National Institute on Drug Abuse</p>

      <p><b>Goal Statement:</b></p>
      <p>Reduce opioid-related morbidity and mortality through: 1) improving access to prevention, treatment and recovery support services; 2) targeting the availability and distribution of overdose-reversing drugs; 3) strengthening public health data and reporting; 4) supporting cutting-edge research; and 5) advancing the practice of pain management.
 </p>
 <p>Starting from the baseline of September 30, 2017, by September 30, 2019:</p>
   <ol>
     <li>Reduce opioid prescribing as measured by morphine milligram equivalents (MME):</li>
     <ol type="a">
       <li>Decrease by 25% the MME of opioid analgesics dispensed in U.S. outpatient retail pharmacies
</li>
<li>Decrease by 10% the morphine milligram equivalents (MME) in opioid analgesic prescriptions dispensed in U.S. outpatient retail pharmacies.
</li>
</ol>
     <li>Increase naloxone access: </li>
     <ol type="a">
       <li>Increase by 30% the number of prescriptions dispensed for naloxone in U.S. outpatient retail pharmacies.
</li>
</ol>
     <li>Increase uptake of medications for the treatment of opioid use disorder:
</li>
<ol type="a">
  <li>Increase by 25% the number of unique patients receiving prescriptions for buprenorphine in U.S. outpatient retail pharmacies (excluding implantable or long-acting injection products).
</li>
<li>Increase by 100% the number of prescriptions for long-acting injectable or implantable buprenorphine from retail, long-term care, and mail-order pharmacies in the U.S.
</li>
<li>Increase by 25% the number of prescriptions for extended-released naltrexone from retail, long-term care, and mail-order pharmacies in the U.S.
</li>
</ul>
   </ol>
 </p>
    <!-- <p><strong>Implementation Action Plans will be available with the Q1 FY 2018 performance update.</strong></p>-->
    <p><b>Goal Action Plan & Progress Update:</b></p>
    <div class="usa-grid usa-graphic_list-row" style="padding-left:0rem;">
      <div class="usa-width-one-whole usa-media_block">
        <p><img src="../img/PDF_icon.png" alt="pdftest" style="float:left;width:50px;align:bottom;"><a class="usa-external_link" target="_blank" href="FY2018_Q2_HHS_Reducing_Opioid_Morbidity_and_Mortality.pdf">FY 2018, Quarter 2</a></p>
      </div>
    </div>
    <div class="usa-grid usa-graphic_list-row" style="padding-left:0rem;">
      <div class="usa-width-one-whole usa-media_block">
        <p><img src="../img/PDF_icon.png" alt="pdftest" style="float:left;width:50px;align:bottom;"><a class="usa-external_link" target="_blank" href="FY2018_Q1_HHS_Reducing_Opioid_Morbidity_and_Mortality.pdf">FY 2018, Quarter 1</a>.</p>
      </div>
    </div>
          </div>
